Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

By Murdaca Giuseppe  

American Journal of Clinical Dermatology, Vol. 11, Iss. 6, 2010-12 ,pp. : 437-439

Adis International

Access to resources Recommend Favorite

The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease

By Reguiaï Ziad   Grange Florent  

American Journal of Clinical Dermatology, Vol. 8, Iss. 2, 2007-01 ,pp. : 67-77

Adis International

Access to resources Recommend Favorite

Side effects of cancer treatment with recombinant human tumour necrosis factor alpha: a new challenge for the intensive care unit

By ZWAVELING J H   MARING J K   GIRIBES A R J   KOOPS H SCHRAFFORDT  

Clinical Intensive Care, Vol. 8, Iss. 3, 1997-06 ,pp. : 142-150

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata: First 120 Cases from the Literature Including a Series of Six New Patients

By Wollina Uwe  

American Journal of Clinical Dermatology, Vol. 9, Iss. 1, 2008-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite

Targeting Tumour Necrosis Factor in the Treatment of Rheumatoid Arthritis

By Pearce G.J.   Chikanza I.C.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 139-149

Adis International

Access to resources Recommend Favorite